Search results
Pfizer's (PFE) Etrasimod Filings Receive Review Acceptance
Zacks via Yahoo Finance· 1 year agoThe regulatory filings seek approval for Pfizer's (PFE) etrasimod in UC indication. A final decision...
Pfizer's (PFE) Ulcerative Colitis Pill Etrasimod Gets FDA Nod
Zacks via Yahoo Finance· 8 months agoPfizer PFE announced that the FDA has granted approval to its oral, once-daily pill called etrasimod...
Could This Drug News Be a Catalyst for This Big Pharma Stock?
Motley Fool· 1 year agoPfizer's (NYSE: PFE) Marketing Authorization Application for the drug candidate called etrasimod was...
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Motley Fool· 2 years agoIn late May, pharmaceutical giant Pfizer (NYSE: PFE) released positive phase-three clinical trial...
Pfizer Has a New Oral Pill for Ulcerative Colitis
Verywell Health via Yahoo News· 8 months agoThe FDA approved Velsipity (etrasimod), a drug by Pfizer to treat ulcerative colitis. The approval adds another treatment option for patients who respond...
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks via Yahoo Finance· 2 months agoBristol Myers BMY announced that a late-stage study on orally-administered Zeposia (ozanimod) in...
Pharma Stock Roundup: Pfizer's Velsipity Receives EU Nod, ABBV Gets New CEO & More
Zacks via Yahoo Finance· 4 months agoThis week, Pfizer’s PFE Velsipity (etrasimod), an ulcerative colitis (UC) pill, was approved in the...
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 30, 2023 – Zacks.com announces the list of stocks...
Pharma Stock Roundup: JNJ Posts Upbeat Q3 Earnings, PFE, NVO Revise 2023 View
Zacks via Yahoo Finance· 8 months agoJ&J (JNJ) reports strong third-quarter results. Merck's (MRK) new deal with Japan's Daiichi Sankyo...
Roivant, Pfizer team up on inflammatory disease drug
Reuters via Yahoo News· 2 years ago(Reuters) -Biotech firm Roivant Sciences on Thursday launched a company with Pfizer Inc focused on an experimental bowel disease treatment, as the...